Clinical Trial Update: Treatment of Acute Leukemia Relapse After Allotransplantation [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing a Phase 1/2 study for treating relapse of acute myeloid leukemia after allogeneic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University of Bergen | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN